Sari, A. Et Al. 2017. Rituximab experience in patients with long-standing systemic sclerosis-associated interstitial lung disease: A series of 14 patients. Journal of Clinical Rheumatology , vol.23, no.8 , 411-415.

Sari, A., Guven, D., Armagan, B., Erden, A., KALYONCU, U., KARADAĞ, Ö., ... Apras Bilgen, S.(2017). Rituximab experience in patients with long-standing systemic sclerosis-associated interstitial lung disease: A series of 14 patients. Journal of Clinical Rheumatology , vol.23, no.8, 411-415.

Sari, Alper Et Al. "Rituximab experience in patients with long-standing systemic sclerosis-associated interstitial lung disease: A series of 14 patients," Journal of Clinical Rheumatology , vol.23, no.8, 411-415, 2017

Sari, Alper Et Al. "Rituximab experience in patients with long-standing systemic sclerosis-associated interstitial lung disease: A series of 14 patients." Journal of Clinical Rheumatology , vol.23, no.8, pp.411-415, 2017

Sari, A. Et Al. (2017) . "Rituximab experience in patients with long-standing systemic sclerosis-associated interstitial lung disease: A series of 14 patients." Journal of Clinical Rheumatology , vol.23, no.8, pp.411-415.

@article{article, author={Alper Sari Et Al. }, title={Rituximab experience in patients with long-standing systemic sclerosis-associated interstitial lung disease: A series of 14 patients}, journal={Journal of Clinical Rheumatology}, year=2017, pages={411-415} }